United States - English - NLM (National Library of Medicine)

mylan consumer healthcare, inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t), rosa canina leaf (unii: j3n2z889qp) (rosa canina leaf - unii:j3n2z889qp), echinacea purpurea (unii: qi7g114y98) (echinacea purpurea - unii:qi7g114y98), avena sativa leaf (unii: 206pi19v7r) (avena sativa leaf - unii:206pi19v7r) - cold remedy promotes immune support* helps with general debility and fatigue* promotes immune support* promotes immune support* taking minocycline, doxycycline, tetracycline or are on coumadin (warfarin) therapy. zinc treatment may inhibit the absorption of these medicines. symptoms persist beyond 7 days.

Philippines - English - FDA (Food And Drug Administration)

golden dale pharma corp.; importer: n/a; distributor: n/a - ascorbic acid , d-alpha tocopherol (vitamin e) , zinc - film-coated tablet - 500 mg (equivalent to 562.43 mg sodium ascorbate) /22 iu/10 mg (equivalent to 27.45 mg zinc sulfate. monohydrate)

United States - English - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - pioglitazone 15 mg - actoplus met xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate [see clinical studies (14)] . important limitations of use pioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin. actoplus met xr should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.5)]. - initiation in patients with established nyha class iii or iv heart failure [see boxed warning] . - severe renal impairment ( egfr below 30 ml/min/1.73 m2 ) [see warnings and precautions (5.2)]. - use in patients with known hypersensitivity to pioglitazone, metformin or any other component of actoplus met xr. - metabolic acidosis, including diabetic ketoacidosis. diabetic ketoacidosis should be treated with insulin. risk summary

United States - English - NLM (National Library of Medicine)

hameln pharma gmbh - pentetate zinc trisodium (unii: nxu65ic8pg) (pentetic acid - unii:7a314hqm0i) - pentetate zinc trisodium 1000 mg in 5 ml - zn-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none. pregnancy category b risk summary there are no adequate and well-controlled studies of zn-dtpa use in pregnant women. chelation treatment of pregnant women should begin and continue with zn-dtpa. reproduction studies have been performed in pregnant mice at doses up to 31 times (11.5 mmol/kg) the recommended daily human dose and have revealed no evidence of impaired fertility or harm to the fetus due to zn-dtpa. there was a slight reduction in the average birth weight. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. it is not known whether zn-dtpa is excreted in human milk. radiocontaminants are known to be excreted in breast milk. women with known or suspected internal contamination with radiocontaminants should not breast feed, whether

Philippines - English - FDA (Food And Drug Administration)

golden dale pharma corp. - carbocisteine , zinc - film coated tablet - 500mg / 5mg (equivalent to 13.720mg zinc sulfate monohydrate)

Philippines - English - FDA (Food And Drug Administration)

united pharma plus (unipharma), inc - rosuvastatin (as calcium) - tablet, film coated - 20mg

Philippines - English - FDA (Food And Drug Administration)

united pharma plus (unipharma), inc - pantoprazole - delayed release tablet - 40 mg

European Union - English - EMA (European Medicines Agency)

janssen-cilag international n.v. - telaprevir - hepatitis c, chronic - antivirals for systemic use - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype-1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis):who are treatment naïve;who have previously been treated with interferon alfa (pegylated or non-pegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.

Ireland - English - HPRA (Health Products Regulatory Authority)

provimi ltd - zinc oxide - premix for medicated feeding stuff - 100 percent - zinc oxide - pigs - miscellaneous

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - alendronate sodium (unii: 2uy4m2u3ra) (alendronic acid - unii:x1j18r4w8p), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41) - alendronic acid 70 mg - fosamax® plus d is indicated for: for the treatment of osteoporosis, fosamax plus d increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). fosamax plus d alone should not be used to treat vitamin d deficiency. the safety and effectiveness of fosamax plus d for the treatment of osteoporosis are based on clinical data of four years duration. the optimal duration of use has not been determined. all patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.1)] - inability to stand or sit upright for at least 30 minutes [see dosage and administration (2.3), warnings and precautions (5.1)] - hypocalcemia [see warnings and precautions (5.2)] - hypersensitivity to any component of this product. hypersensitivity reactions including urticaria and angioedema have